Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar

Last updated: February 28, 2023
Sponsor: Massachusetts General Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Scar Tissue

Hyponatremia

Skin Wounds

Treatment

N/A

Clinical Study ID

NCT03692273
MB170043
  • Ages > 18
  • All Genders

Study Summary

Laser treatment of hypertrophic burn scars has become increasingly popular for improving scarring in burn survivors. Despite its common use, there a gap in knowledge regrading randomized control trials that demonstrate whether the laser is beneficial. Such a trial is important because if it shows the laser does work, it would provide the evidence to make such treatments more accessible to all patients.

Furthermore, there is no knowledge whether the burn injury used to remove tissue is beneficial or not. This study aims to evaluate the laser treatment, removal of similar tissue amounts with 0.5mm punch biopsies, to controls to fill this knowledge gap.

The hypothesis is the laser is beneficial at improving patient's burn scars. Also the punch biopsies work better at improving scars by removing tissue without burning and injuring the surrounding tissue as the laser does.

To evaluate these treatments (laser, punch biopsies, and no treatment), 3 small areas will be chosen in a study scar area that meets specific criteria to receive . Patients will still be able to receive laser and burn reconstruction procedures in all other areas not involving the study scar area that are clinically indicated.

In the study, the scar will be evaluated with photographs, surveys, and tissue samples taken either while under anesthesia except for one set taken with numbing medicine. The tissue samples will be looked at under a microscope to see how the treatments change the scar tissue. The tissue will also have tests done to evaluate how the laser impacts genes from cells in the scar tissue.

Lastly, to understand how reconstructive procedures (laser and surgical treatments) change a patient's quality of life, patients will be asked a limited set of questions to learn more how these procedures improve their lives.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients must be 18 years of age or older
  • Must be medically fit to undergo laser/reconstructive procedure
  • Must have symptomatic HTBS for which they are already planning to undergo lasertreatment. The symptomatic HTBSs may include the study scar area, but there must beother areas that the patient is getting treated with laser besides the study scar.
  • The HTBS must have occurred from a burn injured area either treated by skin grafts orallowed to heal secondarily.
  • Be willing and able to participate in the study with a year of follow-up
  • Must be able to answer surveys on their own, and not rely on surrogates
  • Not be pregnant or planning to become pregnant during the treatment phase of the study Study Scar Inclusion Criteria:
  • The study scar must be at least 3mm thick
  • For Extremities, no surgical treatment can be performed on joint space above or belowthe target area
  • If the study scar is over a joint, then no surgical treatments can occur to thebody part above or below it
  • When the study scar is on the trunk or neck, it must not be on continuity or adjacentto any area of planned surgical treatment.
  • Study Scar Size: The study scar can either be within an area of homogenous HTBS or bean area of HTBS surrounded by normal tissue if it meets the following size criteria:
  • Within HTBS For treatment areas within burn scars, it must be 65cm2 or larger topermit 3 treatment areas that are 3 x 3cm with a 1cm wide segment of untreated scarbetween it.
  • Surrounded by normal tissue For treatment areas surrounded by normal skin, thetreatment area must be 33cm2 or greater, contain similar 3x3cm treatment areas, andhave intervening segments of 1cm of scar between treatment areas. A border around thescar, is not required here because it is surrounded by normal skin.

Exclusion

Exclusion Criteria:

  • Previous laser or reconstructive procedures for the treatment of their HTBS in thestudy scar or adjacent tissue.
  • Steroids, immunosuppressive medications, chemotherapy or other medications that candelay their wound healing/immune function.
  • Medical Conditions that preclude laser treatment or general anesthesia if needed
  • Cognitively unable to complete PROMs on their own
  • The study area should not be part of a contracture or other hypertrophic scar thatwould be better treated with surgical procedures.
  • The study scar must not be adjacent to/in continuity with areas of HTBS that areplanning to be treated with surgical interventions.

Study Design

Total Participants: 120
Study Start date:
March 20, 2019
Estimated Completion Date:
December 01, 2024

Connect with a study center

  • Massachusetts General Hospital

    Boston, Massachusetts 02114
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.